

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.09664708 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.84682742 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.84682742 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.84682742 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.84682742 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.84682742 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.84682742 |
| 8 | response to peptidoglycan (GO:0032494) | 5.45186778 |
| 9 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.23953499 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.12089475 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.12089475 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 5.05522125 |
| 13 | cellular extravasation (GO:0045123) | 5.00019421 |
| 14 | detection of other organism (GO:0098543) | 4.95820757 |
| 15 | neutrophil activation (GO:0042119) | 4.95377525 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.86220779 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85964148 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.84237961 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.74953932 |
| 20 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.70223816 |
| 21 | granulocyte activation (GO:0036230) | 4.59572503 |
| 22 | detection of bacterium (GO:0016045) | 4.47557643 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.45805509 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.38642515 |
| 25 | response to host immune response (GO:0052572) | 4.05102229 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.05102229 |
| 27 | detection of biotic stimulus (GO:0009595) | 3.99659047 |
| 28 | microglial cell activation (GO:0001774) | 3.96747341 |
| 29 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.90870961 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90388797 |
| 31 | leukocyte aggregation (GO:0070486) | 3.88767920 |
| 32 | neutrophil mediated immunity (GO:0002446) | 3.88679174 |
| 33 | macrophage activation (GO:0042116) | 3.87637651 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.85414320 |
| 35 | germinal center formation (GO:0002467) | 3.82772899 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80253986 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75685191 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.75510116 |
| 39 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.74616565 |
| 40 | respiratory burst (GO:0045730) | 3.72422282 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 3.71485647 |
| 42 | response to host (GO:0075136) | 3.68655800 |
| 43 | response to host defenses (GO:0052200) | 3.68655800 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68655800 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.64673602 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.59094495 |
| 47 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.59094495 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.57402332 |
| 49 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.55334931 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.54373628 |
| 51 | regulation of gamma-delta T cell activation (GO:0046643) | 3.52795242 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.52267425 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.52065608 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.49478476 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.35772942 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33331902 |
| 57 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.32455178 |
| 58 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30230882 |
| 59 | leukocyte degranulation (GO:0043299) | 3.30002634 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.26032510 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.25446350 |
| 62 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.25229892 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.24130626 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.21023898 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.16903277 |
| 66 | neutrophil chemotaxis (GO:0030593) | 3.16647254 |
| 67 | myeloid leukocyte mediated immunity (GO:0002444) | 3.14697271 |
| 68 | regulation of platelet aggregation (GO:0090330) | 3.13129213 |
| 69 | response to interleukin-15 (GO:0070672) | 3.12443799 |
| 70 | defense response to protozoan (GO:0042832) | 3.10975213 |
| 71 | negative regulation of T cell mediated immunity (GO:0002710) | 3.08817658 |
| 72 | neutrophil migration (GO:1990266) | 3.08304331 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.07531019 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07531019 |
| 75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00751319 |
| 76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00053125 |
| 77 | negative regulation of interleukin-6 production (GO:0032715) | 2.99756615 |
| 78 | negative regulation of interleukin-17 production (GO:0032700) | 2.99515857 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.97733028 |
| 80 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.96398297 |
| 81 | myeloid leukocyte activation (GO:0002274) | 2.96176732 |
| 82 | B cell mediated immunity (GO:0019724) | 2.92769749 |
| 83 | dendritic cell chemotaxis (GO:0002407) | 2.89744062 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 2.88021463 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 2.86315689 |
| 86 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.85947042 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.84401848 |
| 88 | regulation of interleukin-17 production (GO:0032660) | 2.82978778 |
| 89 | dendritic cell migration (GO:0036336) | 2.82975681 |
| 90 | regulation of macrophage cytokine production (GO:0010935) | 2.81671932 |
| 91 | type I interferon signaling pathway (GO:0060337) | 2.80939842 |
| 92 | cellular response to type I interferon (GO:0071357) | 2.80939842 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.80612536 |
| 94 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.80521463 |
| 95 | positive regulation of interleukin-10 production (GO:0032733) | 2.80447940 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.78804664 |
| 97 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.77911776 |
| 98 | response to type I interferon (GO:0034340) | 2.77498680 |
| 99 | negative regulation of interleukin-1 production (GO:0032692) | 2.76054992 |
| 100 | regulation of interferon-alpha production (GO:0032647) | 2.75860795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.39802178 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.25157719 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21670537 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.83387133 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.37680287 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37399107 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.28285254 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.24364475 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.14087760 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06462834 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 2.71080303 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70263068 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60854568 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54899400 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.54474056 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.47728459 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44220329 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42598553 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39651498 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36738920 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.27270540 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.22885907 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17955466 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12903568 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10441823 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10372502 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.08754093 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99282111 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99121332 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98077864 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97127576 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.95186761 |
| 33 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.94644671 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.92800369 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92462250 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91094482 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90610107 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.90125851 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88756421 |
| 40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.87803009 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86252292 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.85108332 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.81326031 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80903592 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79873228 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77750200 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76479074 |
| 48 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.70104165 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66040256 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62409185 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.57332819 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54222613 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53967370 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.48458529 |
| 55 | GATA2_19941826_ChIP-Seq_K562_Human | 1.47444848 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46026090 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45428294 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45336852 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44583599 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44524738 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41468047 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40371301 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40211476 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32640672 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32456215 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30109161 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29444635 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.28079137 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26491164 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26100574 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25799525 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23920485 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22937294 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21385569 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19722359 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17593998 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15020315 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13411986 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07429714 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07013434 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05735942 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03462925 |
| 83 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98527314 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97232936 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96544009 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96489515 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89015131 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88753830 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88543788 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88220105 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88191902 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87791325 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85814093 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85558046 |
| 95 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83294829 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81907537 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80673507 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78008523 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.77716820 |
| 100 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.70445899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.74081856 |
| 2 | MP0003303_peritoneal_inflammation | 4.95176695 |
| 3 | MP0003436_decreased_susceptibility_to | 4.18169726 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.41551277 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.27062070 |
| 6 | MP0002419_abnormal_innate_immunity | 2.99969706 |
| 7 | MP0008004_abnormal_stomach_pH | 2.78355606 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.68263095 |
| 9 | MP0009785_altered_susceptibility_to | 2.64420818 |
| 10 | MP0005025_abnormal_response_to | 2.61979605 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.46582454 |
| 12 | MP0001790_abnormal_immune_system | 2.41352344 |
| 13 | MP0005387_immune_system_phenotype | 2.41352344 |
| 14 | MP0001800_abnormal_humoral_immune | 2.41320724 |
| 15 | MP0000685_abnormal_immune_system | 2.39543750 |
| 16 | MP0005671_abnormal_response_to | 2.35960416 |
| 17 | MP0002723_abnormal_immune_serum | 2.33908940 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.28552333 |
| 19 | MP0009278_abnormal_bone_marrow | 2.25805393 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.24103636 |
| 21 | MP0008260_abnormal_autophagy | 2.20541277 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.20134662 |
| 23 | MP0006082_CNS_inflammation | 2.16960875 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.16409832 |
| 25 | MP0001819_abnormal_immune_cell | 2.14651669 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.14634415 |
| 27 | MP0004510_myositis | 2.06522843 |
| 28 | MP0002132_abnormal_respiratory_system | 2.01529029 |
| 29 | MP0009764_decreased_sensitivity_to | 2.01106682 |
| 30 | MP0003828_pulmonary_edema | 1.94896027 |
| 31 | MP0004947_skin_inflammation | 1.93588264 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.90161784 |
| 33 | MP0002405_respiratory_system_inflammati | 1.79737389 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.76825829 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.75867056 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.75867056 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.70110048 |
| 38 | MP0003075_altered_response_to | 1.69633840 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.66904900 |
| 40 | MP0002398_abnormal_bone_marrow | 1.66393800 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.59523067 |
| 42 | MP0000716_abnormal_immune_system | 1.57396289 |
| 43 | MP0000343_altered_response_to | 1.48921927 |
| 44 | MP0005451_abnormal_body_composition | 1.48286511 |
| 45 | MP0000858_altered_metastatic_potential | 1.38932716 |
| 46 | MP0008469_abnormal_protein_level | 1.34627688 |
| 47 | MP0002722_abnormal_immune_system | 1.32841721 |
| 48 | MP0002429_abnormal_blood_cell | 1.29985290 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.29925701 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.28970363 |
| 51 | MP0001851_eye_inflammation | 1.28169787 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.28136691 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.27826582 |
| 54 | MP0005164_abnormal_response_to | 1.24550654 |
| 55 | MP0004883_abnormal_blood_vessel | 1.20653520 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.17697535 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.17684838 |
| 58 | MP0005166_decreased_susceptibility_to | 1.15818178 |
| 59 | MP0003866_abnormal_defecation | 1.15457752 |
| 60 | MP0005310_abnormal_salivary_gland | 1.10837437 |
| 61 | MP0003448_altered_tumor_morphology | 1.09390539 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.06893174 |
| 63 | MP0009763_increased_sensitivity_to | 1.05418641 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.01380354 |
| 65 | MP0004381_abnormal_hair_follicle | 0.99724719 |
| 66 | MP0009765_abnormal_xenobiotic_induced | 0.98271125 |
| 67 | MP0000703_abnormal_thymus_morphology | 0.97505118 |
| 68 | MP0001663_abnormal_digestive_system | 0.94301065 |
| 69 | MP0005390_skeleton_phenotype | 0.93753035 |
| 70 | MP0002332_abnormal_exercise_endurance | 0.93511705 |
| 71 | MP0005083_abnormal_biliary_tract | 0.89949438 |
| 72 | MP0003045_fibrosis | 0.86779319 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.86324042 |
| 74 | MP0002396_abnormal_hematopoietic_system | 0.85276589 |
| 75 | MP0000249_abnormal_blood_vessel | 0.81780335 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.79477386 |
| 77 | MP0001853_heart_inflammation | 0.78721325 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.77700375 |
| 79 | MP0003690_abnormal_glial_cell | 0.77602276 |
| 80 | MP0008874_decreased_physiological_sensi | 0.75989327 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 0.72709413 |
| 82 | MP0003878_abnormal_ear_physiology | 0.72709413 |
| 83 | MP0004130_abnormal_muscle_cell | 0.72002933 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69252739 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.67283672 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.66209390 |
| 87 | MP0003795_abnormal_bone_structure | 0.65381772 |
| 88 | MP0004484_altered_response_of | 0.64554609 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.61450348 |
| 90 | MP0003091_abnormal_cell_migration | 0.59843708 |
| 91 | MP0006054_spinal_hemorrhage | 0.59329555 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.59133858 |
| 93 | MP0005535_abnormal_body_temperature | 0.55177563 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.54917917 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.54806140 |
| 96 | MP0009840_abnormal_foam_cell | 0.54056355 |
| 97 | MP0000490_abnormal_crypts_of | 0.52536706 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.52194811 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.50451607 |
| 100 | MP0000604_amyloidosis | 0.50212260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.00455828 |
| 2 | Orchitis (HP:0100796) | 5.83703605 |
| 3 | Myositis (HP:0100614) | 5.72315601 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.59028026 |
| 5 | Optic neuritis (HP:0100653) | 5.59028026 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.48069736 |
| 7 | Recurrent abscess formation (HP:0002722) | 5.35993488 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.33276273 |
| 9 | Stomatitis (HP:0010280) | 5.28298308 |
| 10 | Prolonged bleeding time (HP:0003010) | 5.21303487 |
| 11 | Petechiae (HP:0000967) | 4.48911817 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.48057649 |
| 13 | Spontaneous hematomas (HP:0007420) | 4.31805615 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.27974565 |
| 15 | Gingival bleeding (HP:0000225) | 4.26829425 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 4.19677786 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 4.07324259 |
| 18 | Epistaxis (HP:0000421) | 4.00759071 |
| 19 | Keratoconjunctivitis (HP:0001096) | 3.85015136 |
| 20 | Obstructive lung disease (HP:0006536) | 3.80286525 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80286525 |
| 22 | Purpura (HP:0000979) | 3.75425579 |
| 23 | Abnormal platelet volume (HP:0011876) | 3.74285181 |
| 24 | Increased IgE level (HP:0003212) | 3.72133567 |
| 25 | Encephalitis (HP:0002383) | 3.60922530 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.52834799 |
| 27 | Episodic fever (HP:0001954) | 3.51328716 |
| 28 | Urticaria (HP:0001025) | 3.43208864 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.42875002 |
| 30 | Vasculitis (HP:0002633) | 3.40688207 |
| 31 | Recurrent skin infections (HP:0001581) | 3.38686753 |
| 32 | Meningitis (HP:0001287) | 3.37512411 |
| 33 | Menorrhagia (HP:0000132) | 3.34455939 |
| 34 | Arterial thrombosis (HP:0004420) | 3.31780881 |
| 35 | Gangrene (HP:0100758) | 3.09687169 |
| 36 | Chest pain (HP:0100749) | 3.09183332 |
| 37 | Gingivitis (HP:0000230) | 3.08998015 |
| 38 | Increased mean platelet volume (HP:0011877) | 3.08742323 |
| 39 | Peritonitis (HP:0002586) | 3.06980651 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06860424 |
| 41 | Anorexia (HP:0002039) | 2.98340915 |
| 42 | Hemoptysis (HP:0002105) | 2.88215445 |
| 43 | Amyloidosis (HP:0011034) | 2.84633374 |
| 44 | Increased IgM level (HP:0003496) | 2.81265915 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.80623574 |
| 46 | Leukocytosis (HP:0001974) | 2.80449049 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.77878087 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75513792 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75513792 |
| 50 | Pulmonary embolism (HP:0002204) | 2.73422040 |
| 51 | Hypochromic anemia (HP:0001931) | 2.55635023 |
| 52 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.54689828 |
| 53 | Cellulitis (HP:0100658) | 2.54323795 |
| 54 | Impaired platelet aggregation (HP:0003540) | 2.50594244 |
| 55 | Abnormal platelet function (HP:0011869) | 2.50594244 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.44813412 |
| 57 | Increased serum ferritin (HP:0003281) | 2.40170482 |
| 58 | Vertigo (HP:0002321) | 2.36264635 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.35689624 |
| 60 | Microcytic anemia (HP:0001935) | 2.33199762 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.31413920 |
| 62 | Pustule (HP:0200039) | 2.27086489 |
| 63 | Glomerulopathy (HP:0100820) | 2.27011653 |
| 64 | T lymphocytopenia (HP:0005403) | 2.24591443 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.23406403 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.23116709 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.22554343 |
| 68 | Abnormality of the endocardium (HP:0004306) | 2.21872003 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.21035299 |
| 70 | Granulocytopenia (HP:0001913) | 2.19944166 |
| 71 | Sepsis (HP:0100806) | 2.19756015 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.17554385 |
| 73 | Keratitis (HP:0000491) | 2.16969499 |
| 74 | Osteomyelitis (HP:0002754) | 2.16887967 |
| 75 | Joint swelling (HP:0001386) | 2.11197386 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.10004650 |
| 77 | Bruising susceptibility (HP:0000978) | 2.09079298 |
| 78 | Acne (HP:0001061) | 2.07685191 |
| 79 | Recurrent viral infections (HP:0004429) | 2.05502410 |
| 80 | Polyneuropathy (HP:0001271) | 1.99188939 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 1.96776331 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95654947 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95654947 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95654947 |
| 85 | Thrombophlebitis (HP:0004418) | 1.94787274 |
| 86 | Eosinophilia (HP:0001880) | 1.94423315 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 1.92327453 |
| 88 | Loss of speech (HP:0002371) | 1.92311380 |
| 89 | Premature loss of primary teeth (HP:0006323) | 1.91869602 |
| 90 | Abnormality of T cells (HP:0002843) | 1.90896117 |
| 91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90822437 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90399405 |
| 93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89813353 |
| 94 | Polycythemia (HP:0001901) | 1.88430878 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 1.87697589 |
| 96 | Abnormality of the pericardium (HP:0001697) | 1.86546688 |
| 97 | Arthralgia (HP:0002829) | 1.84572140 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83055822 |
| 99 | Skin ulcer (HP:0200042) | 1.79983896 |
| 100 | Acute hepatic failure (HP:0006554) | 1.78283171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.17068791 |
| 2 | IRAK4 | 3.43059237 |
| 3 | MAP2K3 | 3.12374272 |
| 4 | BLK | 2.96689975 |
| 5 | MAP4K1 | 2.70836152 |
| 6 | CSK | 2.54854774 |
| 7 | ERN1 | 2.51300184 |
| 8 | TYK2 | 2.39027066 |
| 9 | EPHB1 | 2.28393964 |
| 10 | ZAP70 | 2.25551665 |
| 11 | MAP3K3 | 2.25484984 |
| 12 | TAOK1 | 2.24663997 |
| 13 | IRAK3 | 2.01840730 |
| 14 | GRK6 | 2.00430116 |
| 15 | TNK2 | 1.99161208 |
| 16 | FES | 1.91520850 |
| 17 | TXK | 1.86405247 |
| 18 | FGR | 1.85240638 |
| 19 | IRAK1 | 1.81345602 |
| 20 | MAP3K14 | 1.80627212 |
| 21 | MAP3K11 | 1.78483168 |
| 22 | HCK | 1.77651015 |
| 23 | SIK3 | 1.70076761 |
| 24 | BTK | 1.69000188 |
| 25 | PRPF4B | 1.64667720 |
| 26 | IRAK2 | 1.63948972 |
| 27 | JAK3 | 1.60393286 |
| 28 | KSR2 | 1.57171733 |
| 29 | SYK | 1.55695081 |
| 30 | TAOK3 | 1.53503627 |
| 31 | TAOK2 | 1.51983466 |
| 32 | MAP3K1 | 1.51313390 |
| 33 | IKBKE | 1.50899203 |
| 34 | JAK2 | 1.48375084 |
| 35 | MATK | 1.48154557 |
| 36 | TBK1 | 1.42491223 |
| 37 | LYN | 1.32251541 |
| 38 | BMPR2 | 1.28304515 |
| 39 | YES1 | 1.20187067 |
| 40 | IKBKB | 1.17530059 |
| 41 | MARK3 | 1.08178033 |
| 42 | JAK1 | 1.07370113 |
| 43 | CSF1R | 1.06753635 |
| 44 | MAP3K13 | 1.02810075 |
| 45 | PIK3CG | 1.02337162 |
| 46 | EPHA3 | 0.96012509 |
| 47 | MAP3K5 | 0.93935069 |
| 48 | MAP3K6 | 0.93667153 |
| 49 | PTK2B | 0.92548434 |
| 50 | MARK2 | 0.89195050 |
| 51 | BMX | 0.88614244 |
| 52 | TEC | 0.88490066 |
| 53 | LCK | 0.85771776 |
| 54 | MAP3K2 | 0.82177827 |
| 55 | PDK1 | 0.82049187 |
| 56 | TESK2 | 0.81301408 |
| 57 | PRKD2 | 0.80241448 |
| 58 | PDPK1 | 0.79374402 |
| 59 | KIT | 0.71792304 |
| 60 | DAPK2 | 0.71790457 |
| 61 | MAP2K4 | 0.69273128 |
| 62 | KSR1 | 0.63611237 |
| 63 | PTK6 | 0.63204214 |
| 64 | CDC42BPA | 0.62514181 |
| 65 | SGK3 | 0.62379130 |
| 66 | SIK2 | 0.62006050 |
| 67 | ITK | 0.60642620 |
| 68 | SIK1 | 0.60537989 |
| 69 | RAF1 | 0.59866975 |
| 70 | FYN | 0.58926457 |
| 71 | STK10 | 0.56871770 |
| 72 | MAPK12 | 0.54850453 |
| 73 | HIPK2 | 0.51333525 |
| 74 | STK38 | 0.50920943 |
| 75 | DYRK1B | 0.50572898 |
| 76 | DYRK3 | 0.50088702 |
| 77 | RET | 0.48697514 |
| 78 | TGFBR2 | 0.47305960 |
| 79 | WNK1 | 0.47123027 |
| 80 | LRRK2 | 0.46111192 |
| 81 | PIM1 | 0.45855741 |
| 82 | GRK7 | 0.45595724 |
| 83 | MAPK7 | 0.43896884 |
| 84 | SGK2 | 0.41614878 |
| 85 | ACVR1B | 0.41049922 |
| 86 | STK11 | 0.40083958 |
| 87 | MAPKAPK2 | 0.38393884 |
| 88 | MAP2K6 | 0.35871126 |
| 89 | STK24 | 0.35002055 |
| 90 | PRKG2 | 0.34760572 |
| 91 | CHUK | 0.34625848 |
| 92 | MAP3K7 | 0.33048782 |
| 93 | NLK | 0.32631093 |
| 94 | RPS6KL1 | 0.32463764 |
| 95 | RPS6KC1 | 0.32463764 |
| 96 | PRKCZ | 0.31208158 |
| 97 | PRKCD | 0.30880800 |
| 98 | PRKD1 | 0.30589747 |
| 99 | FGFR3 | 0.29414825 |
| 100 | PRKCQ | 0.28522207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.03971357 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81350435 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61000513 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37195199 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.22997936 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20188747 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.15571762 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05097378 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.97666216 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.96119319 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89883010 |
| 12 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.82031062 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75453413 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71027079 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69452851 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.69294931 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68115213 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67894160 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66434223 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.62371283 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58767520 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57944544 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.52844458 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.51548102 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45524399 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45172783 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.42391570 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38780333 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38265679 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.34986730 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32447102 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31901792 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28189820 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.28175955 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.27535894 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.26567753 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.17374661 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16329831 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16070684 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15448084 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12769552 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12043875 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11837383 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.11243553 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09302798 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08542518 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07882830 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05627243 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05050913 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97013185 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.96970751 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94599960 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94372387 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93143878 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92125493 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.90485339 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89543091 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.86811290 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86605795 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85055489 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.82082201 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81356994 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80607072 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79908357 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73416847 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72882657 |
| 67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72396170 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72340398 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72177965 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71878835 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71765848 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70833003 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70149362 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69420954 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68069527 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.65066135 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63920467 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.62880742 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62249006 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62170491 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60896419 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59764500 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59198639 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58492103 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56977284 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55408029 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55368524 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51689270 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51525413 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49757374 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.49399954 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49014395 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48845935 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48117279 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47609173 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46260980 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45160063 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45060950 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43907118 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.42848823 |

